)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Qiagen
Qiagen (QGEN) investor relations material
Qiagen 2026 Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.2026 Global Healthcare Conference summary15 Sep, 2026
Leadership transition and strategic focus
New CEO brings extensive industry experience and aims to drive R&D effectiveness and commercial execution, with a focus on simplifying complexity and aligning with company culture.
Initial 90 days are dedicated to deep listening, learning, and facility visits to assess growth pillars and midterm outlook.
Strategic review is ongoing, with a clear direction expected within weeks, not months.
Diagnostics and QuantiFERON performance
Diagnostics segment saw a 2% decline in Q2, with QuantiFERON impacted by reduced immigration testing, removing $35M from revenue.
U.S. immigration testing revenue is unlikely to return soon, but Middle East volumes may recover over time.
Adjusted QuantiFERON growth is 5–7%, outpacing the 4–5% market rate, with significant market share and expansion opportunities.
60% of customers are now in long-term contracts, and full workflow automation is expected by end of 2027.
Fastest growth is in immunocompromised patient testing, with diabetes as a future opportunity.
Product innovation and automation
QIAstat-Dx platform rebounded to 7% growth in Q2, with expectations for double-digit growth in H2, driven by new panels and instrument placements.
Sample technologies grew 9% in Q2, with three new instruments launched, targeting EUR 20M incremental H2 revenue.
Automation is a key trend, with most sample prep still manual but conversion accelerating.
QIAsprint Connect targets 150 placements this year, aiming for significant consumable pull-through and revenue annuities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Qiagen
- 8% CER non-COVID growth lifted Q4 results; 2024 earnings face non-operating headwinds.QGEN
Q4 2023 - AI-driven automation, new product launches, and margin expansion drive growth amid strategic review.QGENMorgan Stanley 24th Annual Global Healthcare Conference
- Q2 2026 sales and EPS exceeded expectations, driven by strong growth in core pillars.QGENQ2 2026
- New product launches and strategic review drive growth amid leadership transition and stable funding.QGENLeerink Global Healthcare Conference 2026
- 2025 saw robust growth, higher dividends, board renewal, and all AGM proposals adopted.QGENAGM 2026
- Q1 2026 delivered 2% sales growth and solid profitability, with FY 2026 outlook reaffirmed.QGENQ1 2026
- Drives growth in sample prep with automation, high-value applications, and new tech leadership.QGENStatus Update
- 2028 plan targets ~7% sales CAGR, ≥31% margin, and $1B returns, led by innovation and efficiency.QGENCMD 2024
- Exceeded 2024 targets with strong recurring revenue, margin gains, and positive 2025 outlook.QGENQ4 2024
Next Qiagen earnings date
Q3 20264 Nov, 2026
Qiagen
Next Qiagen earnings date
Q3 20264 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Qiagen N.V. is a global biotechnology company specializing in sample and assay technologies for molecular diagnostics, life sciences research, and pharmaceutical development. The company provides solutions for DNA, RNA, and protein analysis, serving applications in disease detection, genetic research, and forensic testing. Qiagen’s products include reagents, instruments, and bioinformatics software used by healthcare providers, academic institutions, and biopharmaceutical companies. Qiagen N.V. is headquartered in Venlo, Netherlands, and its shares are listed on the NYSE and the Frankfurt Stock Exchange.